Singapore markets closed

BioNexus Gene Lab Corp. (BGLC)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.5998-0.2502 (-29.44%)
At close: 04:00PM EDT
0.5888 -0.01 (-1.83%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
11,334
9,771
10,929
13,363
11,390
Cost of revenue
10,011
8,441
9,670
11,096
9,671
Gross profit
1,324
1,329
1,259
2,267
1,720
Operating expenses
Selling general and administrative
1,351
4,409
1,729
1,278
1,333
Total operating expenses
1,291
3,923
1,550
1,211
446.001
Operating income or loss
32.575
-2,594
-291.177
1,056
1,274
Interest expense
11.703
13.929
12.479
12.973
11.313
Total other income/expenses net
-
-
-
-
886.942
Income before tax
20.872
-2,608
-303.656
1,043
1,263
Income tax expense
130.626
21.526
52.31
291.283
168.411
Income from continuing operations
-109.754
-2,629
-355.966
751.571
1,094
Net income
-109.754
-2,629
-355.966
751.571
1,094
Net income available to common shareholders
-109.754
-2,629
-355.966
751.571
1,094
Basic EPS
-0.27
-0.18
-0.05
0.05
0.14
Diluted EPS
-0.27
-0.18
-0.05
0.05
0.14
Basic average shares
12,024
15,875
14,410
14,268
8,577
Diluted average shares
17,793
15,875
14,410
14,268
8,577